Palifermin
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a605017 |
| Routes of administration | intravenous bolus injection |
| ATC code | |
| Identifiers | |
| CAS Number | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| ECHA InfoCard | 100.118.147 |
| Chemical and physical data | |
| Formula | C721H1142N202O204S9 |
| Molar mass | 16192.82 g·mol−1 |
| (what is this?) (verify) | |
Palifermin (trade name Kepivance, marketed by Biovitrum) is a truncated human recombinant keratinocyte growth factor (KGF) produced in Escherichia coli. KGF stimulates the growth of cells that line the surface of the mouth and intestinal tract.